Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 6, 2013, Pages 630-635

  Manner, Hendrik ^a   Pech, Oliver ^b   Heldmann, Yvonne ^a   May, Andrea ^a   Pohl, Juergen ^a   Behrens, Angelika ^a   Gossner, Liebwin ^c   Stolte, Manfred ^d   Vieth, Michael ^e   Ell, Christian ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Oncology and Hematology   (Germany)

^c Hospital Karlsruhe   (Germany)

^d Praxis Kulmbach   (Germany)

^e INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Barrett's Esophagus; Endoscopic Resection; Esophageal Cancer; Neoplasia; Treatment

Indexed keywords

ABLATION THERAPY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CLINICAL EFFECTIVENESS; EARLY CANCER; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; ESOPHAGUS STENOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME; TUMOR INVASION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84878120646     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.12.040     Document Type: Article

References (35)

1. Ell C., May A., Gossner L., et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000, 118:670-677.
2. Ell C., May A., Pech O., et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007, 65:3-10.
3. Pech O., Behrens A., May A., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008, 57:1200-1206.
4. Nijhawan P.K., Wang K.K. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc 2000, 52:328-332.
5. May A., Gossner L., Pech O., et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy 2002, 34:604-610.
6. Seewald S., Akaraviputh T., Seitz U., et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003, 57:854-859.
7. Giovannini M., Bories E., Pesenti C., et al. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer: preliminary results in 21 patients. Endoscopy 2004, 36:782-787.
8. Peters F.P., Kara M.A., Rosmolen W.D., et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 2005, 61:506-514.
9. Behrens A., May A., Gossner L., et al. Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus. Endoscopy 2005, 37:999-1005.
10. Conio M., Cameron A., Chak A., et al. Endoscopic treatment of high-grade dysplasia and early cancer in Barrett's oesophagus. Lancet Oncol 2005, 6:311-321.
11. Larghi A., Lightdale C.J., Ross A.S., et al. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 2007, 39:1086-1091.
12. Hölscher A.H., Vallböhmer D., Bollschweiler E. Early Barrett's carcinoma of the esophagus. Ann Thorac Cardiovasc Surg 2008, 14:347-354.
13. Williams V.A., Watson T.J., Herbella F.A., et al. Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg 2007, 11:1589-1597.
14. Rice T.W. Pro: esophagectomy is the treatment of choice for high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 2006, 101:2177-2179.
15. Buskens C.J., Westerterp M., Lagarde S.M., et al. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 2004, 60:703-710.
16. Westerterp M., Koppert L.B., Buskens C.J., et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005, 446:497-504.
17. Nigro J.J., Hagen J.A., DeMeester T.R., et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 1999, 117:16-23.
18. Stein H.J., Feith M., Bruecher B.L., et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005, 242:566-573.
19. Hölscher A.H., Bollschweiler E., Schneider P.M., et al. Early adenocarcinoma in Barrett's oesophagus. Br J Surg 1997, 84:1470-1473.
20. Stein H.J., Feith M., Mueller J., et al. Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg 2000, 232:733-742.
21. Bollschweiler E., Baldus S.E., Schröder W., et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 2006, 38:149-156.
22. Ancona E., Rampado S., Cassaro M., et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 2008, 15:3278-3288.
23. Badreddine R.J., Prasad G.A., Lewis J.T., et al. Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma. Clin Gastroenterol Hepatol 2010, 8:248-253.
24. Sepesi B., Watson T.J., Zhou D., et al. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma?. an analysis of esophagectomy specimens. J Am Coll Surg 2010, 210:418-427.
25. Griffin S.M., Burt A.D., Jennings N.A. Lymph node metastasis in early esophageal adenocarcinoma. Ann Surg 2011, 254:731-737.
26. Hoelscher A., Bollschweiler E., Schroeder W., et al. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg 2011, 254:802-808.
27. Manner H., May A., Pech O., et al. Early Barrett's carcinoma with "low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 2008, 103:2589-2597.
28. Alvarez Herrero L., Pouw R.E., van Vilsteren F.G., et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy 2010, 42:1030-1036.
29. Koop H., Schepp W., Müller-Lissner S., et al. [Consensus conference of the DGVS on gastroesophageal reflux]. Z Gastroenterol 2005, 43:163-164.
30. Behrens A., Pech O., Graupe F., et al. Barrett's adenocarcinoma of the esophagus: better outcomes through new methods of diagnosis and treatment. Dtsch Arztebl Int 2011, 108:313-319.
31. Stolte M., Kirtil T., Oellig F., et al. The pattern of invasion of early carcinomas in Barrett's esophagus is dependent on the depth of infiltration. Pathol Res Pract 2010, 206:300-304.
32. Vieth M., Stolte M. Pathology of early upper GI cancers. Best Pract Res Clin Gastroenterol 2005, 19:857-869.
33. Spechler S.J., Sharma P., et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011, 140:1084-1091. American Gastroenterological Association.
34. Bennett C., Vakil N., Bergman J., et al. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012, 143:336-346.
35. Tian J., Prasad G.A., Lutzki L., et al. Outcomes of T1b esophageal adenocarcinoma patients. Gastrointest Endosc 2011, 74:1201-1206.